Berry & Company

What Berry & Company does

Berry & Company, doing business as CG Life, is a specialized marketing and communications agency focused on the precision medicine landscape, with explicit concentration on biotech and biopharma companies developing therapies for rare and hard-to-treat diseases. The firm positions itself as a partner guiding clients from clinical development through commercial launch, addressing challenges such as market shaping, patient and HCP engagement, and data-driven launch execution. Its offering is delivered as an integrated portfolio of seven service modules: Brand Strategy, Public Relations & Social Media, Creative, Omnichannel Strategy & Enablement, Scientific Communications, Media Planning, and Analytics & Insights, supported by embedded "scientific ambassadors" who translate complex science into messaging.

The firm was founded in 1993 and is headquartered in New York, with additional U.S. offices in Chicago and San Diego, aligning with the three principal U.S. biotech clusters. Headcount is reported in the 11-50 employee band. Revenue is generated through bespoke professional-services engagements on a retainer or project basis; pricing is not publicly disclosed. Go-to-market is consultative and sales-led, targeting enterprise biopharma clients during the clinical-to-commercial transition.

Operationally, CG Life combines traditional agency capabilities (brand strategy, creative, PR, media planning) with technology-adjacent services. The Omnichannel Strategy & Enablement practice is supported by an in-house tech and DevOps team that aligns content, messaging, and technology for personalized engagement, and the Analytics & Insights practice applies automation and advanced analytics to performance data and customer understanding. No proprietary AI/ML models, patents, or named AI research staff are disclosed, and the firm is best classified as AI-assisted rather than AI-differentiated. Ownership, funding history, and financial performance are not publicly disclosed; no investor information, M&A activity, or funding rounds are reported.

Name

Berry & Company

Legal name

CG Life

Website

https://berrypr.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Berry & Company (dba CG Life) is a specialized marketing and communications agency serving biotech and biopharma companies developing therapies for rare and hard-to-treat diseases. It delivers integrated services spanning brand strategy, public relations, scientific communications, omnichannel enablement, media planning, and analytics.

Ownership category

akta.pro rank

Product category

Healthcare Communications

NAICS

Public Relations Agencies (54182), Advertising Agencies (541810), Advertising, Public Relations, and Related Services (5418)

SIC

Services-Advertising Agencies (7311)

akta.pro primary industry

B2B / Account-Based Marketing (ABM) Strategy Consulting (MPAAAFAM)

Keywords

• Pharmaceutical public relations
• Biotech communications
• Healthcare media relations
• Scientific communications agency
• Biopharma marketing services

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Agency Services Revenue: CG Life generates revenue through providing integrated marketing and communications services to biotech and biopharma companies. Services include brand strategy, public relations, creative campaigns, omnichannel strategy, scientific communications, media planning, and analytics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Berry & Company provides media relations, editorial, and communications services to pharmaceutical, biotechnology, and healthcare organizations. Its integrated capabilities cover brand strategy, public relations and social media, creative, omnichannel strategy and enablement, scientific communications, media planning, and analytics and insights, helping biopharma clients move from clinical development to commercial launch.

Product overview

CG Life is a specialized marketing and communications agency focused on the precision medicine landscape, specifically rare and hard-to-treat diseases. The company operates as a unified service offering rather than a software platform, providing seven integrated service modules: Brand Strategy, Public Relations & Social Media, Creative, Omnichannel Strategy & Enablement, Scientific Communications, Media Planning, and Analytics & Insights. These services work together to guide biopharma companies from clinical development to commercial launch through an integrated approach that combines data-driven strategy with scientific expertise.

Differentiator

Problem solved

Functional benefit

Products and services

• Brand Strategy Strategic brand development service using immersive research, analytics, and scientific understanding to define identity, value propositions, key claims, and a brand strategy playbook for biopharma clients.
• Public Relations & Social Media Integrated PR and social media services that build brand awareness through media engagement, stakeholder outreach, and personalized social content targeting patients, HCPs, and caregivers.
• Creative Conceptual creative services for digital, print, and other media that produce persuasive HCP and patient campaigns reflecting the courage of patients and caregivers.
• Omnichannel Strategy & Enablement Data-driven omnichannel strategy and enablement services aligning content, messaging, and technology to optimize engagement, personalization, and efficiency, supported by in-house tech and DevOps teams.
• Scientific Communications Embedded scientific ambassador services that translate complex science stories and insights into meaningful messaging supporting business, clinical, and communication goals.
• Media Planning Strategic media placement services amplifying content reach through influencer engagement, advocate partnerships, and personalized compliant campaigns for rare disease populations.
• Analytics & Insights Advanced analytics and insights services using automation and data analysis to understand customers, enhance brand impact, and optimize marketing efforts.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Real Chemistry (formerly W2O Group): Large data-driven healthcare marketing and communications firm with deep rare-disease and biotech practice. Directly comparable to Berry & Company / CG Life in serving pharma/biotech clients with integrated communications, but at significantly greater scale.
• Syneos Health Communications: Global healthcare communications and commercial solutions provider serving biopharma across the clinical-to-commercial continuum. Comparable in offering integrated PR, medical communications, and omnichannel services to pharma clients.
• Ogilvy Health: Global health-focused creative, PR, and medical communications agency within WPP. Comparable in serving pharma and biotech clients with integrated brand, PR, and scientific communications, but at far larger scale.
• Edelman (Health Practice): Global communications firm with a substantial health practice serving major pharma and biotech clients. Comparable in offering scientific communications, PR, and health policy work, though much larger and broader.
• McCann Health: Global healthcare marketing network with deep pharma and biotech client base. Comparable in providing scientific storytelling, brand strategy, and integrated launch support to biopharma clients.
• Porter Novelli (Health Practice): Global communications consultancy with a health and life-sciences practice. Comparable in serving pharma clients with PR, scientific communications, and disease-awareness campaigns.
• Burson (BCW): Global communications agency with a significant health and wellness practice. Comparable in offering integrated PR, scientific communications, and health policy support to pharma/biotech clients.

Direct peers

• Finn Partners (Health Practice): Independent global PR and integrated marketing firm with a sizable health and life-sciences practice serving pharma, biotech, and medical device clients. Closely comparable mid-sized peer with similar integrated capabilities and vertical specialization.
• Spectrum Science: Independent health and science communications agency specializing in biotech, pharma, and consumer health. Direct comparable in size, focus, and integrated scientific communications and PR offering.
• Health Unlimited: Specialist healthcare communications group focused on pharma, biotech, and consumer health. Direct mid-sized comparable offering integrated PR, medical communications, and patient engagement services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/CGLifeAgency
• Facebookfacebook.com/BerryCompanyPR
• LinkedInlinkedin.com/company/cglife
• Instagraminstagram.com/CGLifeAgency

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Berry & Company